Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients
NCT05100602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1192
Last updated 2021-11-22
Summary
The purpose of this trail is to evaluate the performance of Genetron TERT PCR Kit in Glioma patients using real-time PCR method.
Conditions
- Glioma, Malignant
Sponsors & Collaborators
-
Huashan Hospital
collaborator OTHER -
Zhejiang University
collaborator OTHER -
West China Hospital
collaborator OTHER -
The First Hospital of Jilin University
collaborator OTHER -
Genetron Health
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-13
- Primary Completion
- 2016-09-22
- Completion
- 2016-12-08
Countries
- China
Study Locations
More Related Trials
-
Integrative Analysis of Human Glioblastoma Multiforme
NCT03005132 ·Status: RECRUITING
-
LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
NCT05663125 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Personalized Trial in ctDNA-level-relapse Glioblastoma
NCT05539339 ·Status: UNKNOWN ·Phase: NA
-
Visual Study of Molecular Genotype in Glioma Evolution
NCT03750890 ·Status: UNKNOWN
-
Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
NCT06363162 ·Status: RECRUITING ·Phase: NA
-
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
NCT03102203 ·Status: UNKNOWN
-
Establishment of a Brain and Spinal Tumor Tissue Bank
NCT00686387 ·Status: UNKNOWN
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas
NCT02795364 ·Status: UNKNOWN ·Phase: NA
-
Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
NCT01089868 ·Status: COMPLETED
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)
NCT05318612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Mapping Molecular Markers of Brain Tumour Activity Using MRI
NCT05140785 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
NCT00756106 ·Status: TERMINATED ·Phase: NA
-
AI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256 ·Status: RECRUITING
-
Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
NCT02941302 ·Status: UNKNOWN ·Phase: NA
-
MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
NCT04217018 ·Status: RECRUITING
-
Recurrent High Grade Glioma Treated by LITT
NCT06161610 ·Status: RECRUITING ·Phase: NA
-
68Ga-citrate PET/MR Imaging for Glioma
NCT03335280 ·Status: TERMINATED
-
Brain Glioma Registry Combining Clinical and Imaging Information
NCT02619890 ·Status: RECRUITING
-
Bioenergetic Profiling and Cognition in GBM Patients
NCT03939858 ·Status: TERMINATED
-
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
NCT00330109 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
NCT00250211 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
NCT04461002 ·Status: COMPLETED
-
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT05541042 ·Status: NOT_YET_RECRUITING